Counting down to ISC 2026!
We look forward to meaningful conversations with leaders and peers across the stroke community! Chat with our experts at booth #407 to discover how the #Genomadix #CYP2C19 Test can help you in your practice!
Visit www.genomadix.com
#MedSky #Neuro #RapidCYP2C19 #ISC26
We look forward to meaningful conversations and collaboration at ISC 2026! Chat with our experts at booth #407 to discover how the #Genomadix #CYP2C19 Test can help you in your practice!
Visit www.genomadix.com
#Medsky #Neuro #Cardio #RapidCYP2C19 #ISC #ISC2026
As the year draws to a close, we hope the holiday season brings you comfort, joy, and time well spent with those who matter most. Wishing you a happy and successful year ahead from the Genomadix team to yours.
#MedSky #Happyholidays #Festive #SeasonGreetings #Joy #Genomadix
We're pleased to welcome Hollie Huff as CEO. Bringing 20+ years in medical technology and diagnostics, she'll guide Genomadix forward in advancing precision medicine.
Visit www.genomadix.com
#WomenInLeadership #WomenInTech #Genomadix #MedSky #MedX #Neuro #RapidCYP2C19 #Cardio #DAPT #RapidTesting
shorturl.at/vdpn2
We're excited to connect with you at the 8th ESPT International Congress! Chat with our experts to discover how the #Genomadix Cube™ Rapid CYP2C19 Test is transforming patient care through advanced #personalized #testing.
Visit www.genomadix.com
#MedSky #Neuro #Cardio #CYP2C19
Following a minor stroke or high-risk TIA, risk of recurrence is 5–10% within 90 days. (1) Learn how the #Genomadix #CYP2C19 test can support your practice by providing more informed DAPT decisions at www.genomadix.com.
1.Wang Y, et al. N Engl J Med. 2021;385:2520-2530.
#MedSky #Neuro #RapidCYP2C19
Today, we’re proud to support healthcare professionals, clinicians, nurses, and laboratorians who ensure that patients receive the best care possible. At Genomadix we’re committed to helping deliver the right treatment, at the right time.
Happy Labor Day!
#Genomadix #MedSky #RapidCYP2C19 #LaborDay
In part three Prof. Dr. Jur ten Berg, Department of Cardiology, explains his implementation of genotype-guided de-escalation treatment in his FORCE-ACS program!
Curious how #Genomadix can aid with DAPT? Listen to the webinar lnkd.in/eUvPDUFm.
Visit www.genomadix.com.
#MedSky #CardioSky #Cardio
High-risk TIA patients have a recurrent #stroke rate up to 17.8% within the first 90 days. (1) Find out how the rapid #Genomadix #CYP2C19 test can help reduce recurrent stroke rates. (2) 🧬
1. Amin HP, et al. Stroke. 2023;54:e109–e121.
2. Wang et al. N Engl J Med. 2021;385:2520-30.
